Search the Archive

Countdown To 2000 (Cancer Treatment: Angiogenesis Inhibitors) #385187

CBS Evening News for Friday, Nov 19, 1999
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Dan Rather) Report introduced.

(No location given: Elizabeth Kaledin) Experimental cancer treatments called angiogenesis inhibitors {SU5416, endostatin, combretastatin} examined; animated diagram shown of how the drugs work. [Colon cancer patient Yuly KIPERVARG - says he had doubts about survival.] [Jonsson Cancer Center Dr. Lee ROSEN - says Yuly's cancer is in remission.] [Cleveland cancer patient Gayle GORDON - hopes a new treatment will save her life.] [Ireland Cancer Center Dr. Scott REMICK - says cancer may be able to be managed; says one man's tumor has disappeared.] [Cancer patient Clayton TWIGG - says he hopes the new drug treatment helps others.]

Kaledin, Elizabeth;
Rather, Dan

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.